Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.68 |
| ▸ | LMNA | P02545 | 4/20 | 0.46 |
| ▸ | TSHR | P16473 | 5/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.35 |
| ▸ | CNR1 | P21554 | 1/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7705881 | 0.88 | ALDH1A1 (0.56) | ALDH1A1LMNATSHRTRPA1TDP1 | |
| SCHEMBL15354042 | 0.88 | ALDH1A1 (0.56) | ALDH1A1LMNATSHRTRPA1TDP1 | |
| SCHEMBL98863 | 0.87 | — | — | |
| SCHEMBL13618584 | 0.87 | — | — | |
| SCHEMBL4986222 | 0.87 | — | — | |
| SCHEMBL8758088 | 0.87 | — | — | |
| SCHEMBL50322 | 0.87 | — | — | |
| SCHEMBL4892117 | 0.87 | ALDH1A1 (0.79) | ALDH1A1LMNATSHRTRPA1TDP1 | |
| SCHEMBL13677489 | 0.86 | TSHR (0.55) | ALDH1A1LMNATSHRTRPA1TDP1 | |
| SCHEMBL17599141 | 0.86 | ALDH1A1 (0.54) | ALDH1A1LMNATSHRTRPA1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3730561-B1 | PAINT, AIRCRAFT PAINT, AND AIRCRAFT | DAINIPPON INK & CHEMICALS (JP) | 2026-02-25 | — | — | EP | disclosed |
| EP-4079777-B1 | CURABLE RESIN COMPOSITION, CURED OBJECT, AND THREE-DIMENSIONAL OBJECT | DAINIPPON INK & CHEMICALS (JP) | 2026-01-28 | — | — | EP | disclosed |
| US-12435219-B2 | Curable resin composition, cured object, and three-dimensional object | DIC CORPORATION (JP) | 2025-10-07 | — | — | US | disclosed |
| US-12202929-B2 | Curable composition and fiber reinforced composite material | DIC CORPORATION (JP) | 2025-01-21 | — | — | US | disclosed |
| CN-115210213-B | Active ester, curable resin composition, and cured product | DIC株式会社 | 2024-12-10 | — | — | CN | disclosed |
| CN-114829431-B | Curable resin composition, cured product, and three-dimensional molded article | DIC株式会社 | 2024-10-15 | — | — | CN | disclosed |
| WO-2024203370-A1 | CURABLE RESIN COMPOSITION, COATING MATERIAL, AND ARTICLE | DIC株式会社 | 2024-10-03 | — | — | WO | disclosed |
| CN-115521435-B | Resin, curable resin composition, cured product, insulating material, and resist member | DIC株式会社 | 2024-02-09 | — | — | CN | disclosed |
| US-20230167228-A1 | CURABLE COMPOSITION AND FIBER REINFORCED COMPOSITE MATERIAL | DIC CORPORATION (JP) | 2023-06-01 | — | — | US | disclosed |
| US-20230056941-A1 | CURABLE RESIN COMPOSITION, CURED OBJECT, AND THREE-DIMENSIONAL OBJECT | DIC CORPORATION (JP) | 2023-02-23 | — | — | US | disclosed |
| US-20130289311-A1 | PRODUCTION OF ALPHA, OMEGA-DIOLS | DUPONT POLYMERS, INC. | 2013-10-31 | — | — | US | disclosed |
| US-20130289319-A1 | PRODUCTION OF ALPHA, OMEGA-DIOLS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-10-31 | — | — | US | disclosed |
| US-20130289318-A1 | PRODUCTION OF ALPHA, OMEGA-DIOLS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-10-31 | — | — | US | disclosed |
| WO-2013163540-A1 | PRODUCTION OF ALPHA, OMEGA-DIOLS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2013-10-31 | — | — | WO | disclosed |
| WO-2013163556-A1 | PRODUCTION OF ALPHA, OMEGA-DIOLS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2013-10-31 | — | — | WO | disclosed |
| US-8025722-B2 | Ink jet ink, ink jet recording method, ink cartridge, recording unit and ink jet recording apparatus | CANON KABUSHIKI KAISHA (JP) | 2011-09-27 | — | — | US | disclosed |
| US-20090238974-A1 | INK JET INK, INK JET RECORDING METHOD, INK CARTRIDGE, RECORDING UNIT, AND INK JET RECORDING APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2009-09-24 | — | — | US | disclosed |
| US-20090238977-A1 | INK JET INK, INK JET RECORDING METHOD, INK CARTRIDGE, RECORDING UNIT AND INK JET RECORDING APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2009-09-24 | — | — | US | disclosed |
| EP-2103660-A2 | Ink jet ink, ink jet recording method, ink cartridge, recording unit and ink jet recording apparatus | Canon Kabushiki Kaisha (JP) | 2009-09-23 | — | — | EP | disclosed |
| CN-101538431-A | Ink jet ink, ink jet recording method, ink cartridge, recording unit and ink jet recording apparatus | CANON KK | 2009-09-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130289311-A1 | PRODUCTION OF ALPHA, OMEGA-DIOLS | HAO2, SCO2, HMOX2 | ALDH1A1 2550/4885LMNA 3765/4885TSHR 4175/4885 |
| US-20130289318-A1 | PRODUCTION OF ALPHA, OMEGA-DIOLS | ALOX12, PTGES3, ALOX5 | ALDH1A1 914/4885LMNA 4347/4885TSHR 2039/4885 |
| US-20130289319-A1 | PRODUCTION OF ALPHA, OMEGA-DIOLS | HAO2, SCO2, CA13 | ALDH1A1 3400/4885LMNA 4090/4885TSHR 2960/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.